SCND on OTC

SCIENTIFIC INDUSTRIES INC

American laboratory analytical instruments company based in Bohemia. Summary from the record

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with Lifeloc Technologies, Inc, Accelerate Diagnostics or Seer, Inc, or pick any stock.

  • TickerSCND on OTC1
  • IndustryLaboratory Analytical Instruments1
  • HeadquartersBohemia, New York1
  • Incorporated inDE2
  • Business address70 Orville Dr, Airport International Plz, Bohemia, Ny 117162
  • Filer categoryNon-accelerated filer, Smaller reporting company2
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

General . Incorporated in 1954, Scientific Industries, Inc., a Delaware corporation (“SI” and along with its subsidiaries, the “Company”), is engaged in the design, manufacture, and marketing of standard benchtop laboratory equipment (“Benchtop Laboratory Equipment”), and through its wholly-owned subsidiary, Scientific Bioprocessing Holdings, Inc., a Delaware corporation (“SBHI”), the design, manufacture, and marketing of bioprocessing systems and products (“Bioprocessing Systems”). SBHI has two wholly-owned subsidiaries – Scientific Bioprocessing, Inc., a Delaware corporation (“SBI”), and aquila biolabs GmbH, a German corporation (“Aquila”). The Company’s products are used primarily for research purposes by universities, pharmaceutical companies, pharmacies, national laboratories, medical device manufacturers, and other industries performing laboratory-scale research. On August 7, 2025,…3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

25.8%Gross margin4
-156.1%Operating margin4
-24.1%Net margin4
5.4%Revenue growth, 20254
-11.4%Return on equity4

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Business segments

Benchtop Laboratory Equipment brought in 74% of the revenue SCIENTIFIC INDUSTRIES INC broke down this way in fiscal 2025.

  1. Benchtop Laboratory Equipment$3.8M474%up 21% from 2024
  2. Bioprocessing Systems$1.3M426%down 23% from 2024
Business segments by year
Business segments20242025
Benchtop Laboratory Equipment$3.1M$3.8M
Bioprocessing Systems$1.7M$1.3M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue60¢$3.8M
  • Research and development40¢$2.5M
  • Income tax0¢$4.6K

Out of $5.1M in revenue.4 The company lost money this year.

Financial statements

Revenue567894$5.1M in 2025−50% since 2019
0$5.0M$10.0M$15.0M2019: $10.2M$10.2M20192020: $7.8M$7.8M2020−24%2021: $9.8M$9.8M2021+26%2022: $11.4M$11.4M2022+17%2023: $11.1M$11.1M2023−3%2024: $4.8M$4.8M2024−57%2025: $5.1M$5.1M2025+5%
Gross profit567894$1.3M in 2025−70% since 2019
0$2.0M$4.0M$6.0M2019: $4.4M$4.4M20192020: $3.9M$3.9M2020−10%2021: $5.0M$5.0M2021+26%2022: $5.7M$5.7M2022+15%2023: $5.1M$5.1M2023−11%2024: $2.0M$2.0M2024−61%2025: $1.3M$1.3M2025−35%
Operating income567894-$7.9M in 2025
-$15.0M-$10.0M-$5.0M0$5.0M2019: $776.1K$776.1K20192020: -$663.5K-$663.5K20202021: -$4.7M-$4.7M2021+610%2022: -$11.5M-$11.5M2022+145%2023: -$9.3M-$9.3M2023−20%2024: -$8.2M-$8.2M2024−11%2025: -$7.9M-$7.9M2025−4%
Net income567894-$1.2M in 2025
-$15.0M-$10.0M-$5.0M0$5.0M2019: $645.6K$645.6K20192020: -$703.3K-$703.3K20202021: -$3.7M-$3.7M2021+422%2022: -$13.7M-$13.7M2022+272%2023: -$9.1M-$9.1M2023−34%2024: -$6.4M-$6.4M2024−29%2025: -$1.2M-$1.2M2025−81%

Every line of the income statement as filed: the last 2 fiscal years, latest first.4

Period ending2025-12-312024-12-31
Revenues$5.1M$4.8M
Cost of revenues$3.8M$2.8M
Gross profit$1.3M$2.0M
General and administrative$3.3M$4.1M
Selling$3.1M$3.2M
Research and development$2.5M$2.9M
Impairment of intangible assets$291.6K$0
Total operating expenses$9.2M$10.2M
Loss from operations-$7.9M-$8.2M
Other income, net$710.9K$12.4K
Gain on disposition of discontinued operations$5.3M$0
Interest income$139.9K$180.4K
Total other income, net$6.1M$192.8K
Loss from continuing operations before income tax expense-$1.8M-$8.0M
Income tax expense, current-$4.6K$0
Total income tax expense-$4.6K$0
Loss from continuing operations-$1.8M-$8.0M
Income from discontinued operations, net of tax$559.9K$1.6M
Net loss-$1.2M-$6.4M
Foreign currency translation gain (loss)$240.9K-$131.7K
Other comprehensive gain (loss)$240.9K-$131.7K
Total comprehensive loss-$979.5K-$6.6M
Continuing operations-$0-$1
Discontinued operations$0$0
Consolidated operations-$0.11-$0.61
Weighted Average Shares Outstanding11.3M shares10.5M shares

Compare SCIENTIFIC INDUSTRIES INC with another company

Leadership

Who has led SCIENTIFIC INDUSTRIES INC, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Helena R. Santos2007–now

Chair

  1. John A. Moore2020–now

President

  1. Helena R. Santos2007–2012
  2. Brookman Peter March2012
  3. Karl Nowosielski2014–2017

Chief financial officer

  1. Reginald Averilla2022–2024
  2. Zachary Rovinsky2025–now
2010201520202025
Board members and other officers (17)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive OfficerRobert Nichols named Mar 4, 202235
  • DirectorChristopher Cox named Mar 4, 2022 to May 1, 202536
  • DirectorJuergen Schumacher named Mar 4, 2022 to May 1, 202536
  • DirectorReinhard Vogt named Mar 4, 202235

Timeline

  1. Jun 21, 2007New chief executive Helena R. Santos becomes CEO12

Filings

198 filings to the SEC since October 2021: 7 annual reports, 15 quarterly reports, 32 major events, 73 insider forms, 28 large holders, 3 private raises, 40 other. The latest 20:

  1. Oct 2, 20268-K EDGAR
  2. Sep 8, 20264 PRIMARY DOCUMENT EDGAR
  3. Aug 20, 20264 PRIMARY DOCUMENT EDGAR
  4. Aug 14, 202610-Q EDGAR
  5. Aug 13, 2026SCHEDULE 13G/A EDGAR
  6. Jun 18, 20264 PRIMARY DOCUMENT EDGAR
  7. May 15, 202610-Q EDGAR
  8. Apr 1, 20264 PRIMARY DOCUMENT EDGAR
  9. Apr 1, 20264 PRIMARY DOCUMENT EDGAR
  10. Mar 31, 202610-K EDGAR
  11. Mar 24, 20264 PRIMARY DOCUMENT EDGAR
  12. Mar 17, 20264 PRIMARY DOCUMENT EDGAR
  13. Mar 17, 20264 PRIMARY DOCUMENT EDGAR
  14. Mar 17, 20264 PRIMARY DOCUMENT EDGAR
  15. Mar 17, 20264 PRIMARY DOCUMENT EDGAR
  16. Mar 17, 20264 PRIMARY DOCUMENT EDGAR
  17. Jan 20, 20268-K EDGAR
  18. Dec 29, 20253 PRIMARY DOCUMENT EDGAR
  19. Dec 29, 2025DEF 14A EDGAR
  20. Dec 18, 20254 PRIMARY DOCUMENT EDGAR

The 198 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

44 open-market trades by officers, directors and large owners since October 2021: 31 buys and 13 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Aug 20, 2026MOORE JOHN AChairman of the BoardBuy5,000$0.76$3.8KForm 4
Aug 20, 2026MOORE JOHN AChairman of the BoardBuy14,700$0.71$10.4KForm 4
Jun 2, 2026MOORE JOHN AChairman of the BoardBuy4,000$0.71$2.8KForm 4
Mar 23, 2026MOORE JOHN AChairman of the BoardBuy9,000$0.58$5.2KForm 4
Feb 19, 2026MOORE JOHN AChairman of the BoardBuy1,000$0.65$650Form 4
Dec 17, 2025MOORE JOHN AChairman of the BoardBuy6,500$0.53$3.4KForm 4
Dec 17, 2025MOORE JOHN AChairman of the BoardBuy11,700$0.54$6.3KForm 4
Dec 5, 2025MOORE JOHN AChairman of the BoardBuy20,000$0.60$12.0KForm 4
Sep 17, 2025MOORE JOHN AChairman of the BoardBuy5,800$0.70$4.1KForm 4
Sep 16, 2025MOORE JOHN AChairman of the BoardBuy9,599$0.64$6.1KForm 4
Apr 18, 2025BLECHMAN MICHAELDirectorBuy10,000$1.00$10.0KForm 4
Apr 18, 2025Bleichroeder LP10% ownerBuy250,000$1.00$250.0KForm 4
Apr 18, 2025NICOLS JOHN JDirectorBuy15,000$1.00$15.0KForm 4
Apr 18, 2025MOORE JOHN AChairman of the BoardBuy35,000$1.00$35.0KForm 4
Oct 31, 2024MOORE JOHN AChairman of the BoardBuy7,000$0.97$6.8KForm 4
Jun 13, 2024MOORE JOHN AChairman of the BoardBuy16,300$1.47$24.0KForm 4
Jan 17, 2024SANTOS HELENA RPresident and CEOBuy11$2.00$22Form 4
Dec 20, 2023MOORE JOHN AChairman of the BoardBuy2,030$2.00$4.1KForm 4
Dec 19, 2023Cox Christopher TDirectorBuy79,245$2.00$158.5KForm 4
Dec 19, 2023MOORE JOHN AChairman of the BoardBuy20,400$2.00$40.8KForm 4

All 44 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

  • Laurence W. LyttonSCHEDULE 13G/A, 6 filings Mar 30, 2022 to Aug 13, 202637
  • Bleichroeder LPSCHEDULE 13D/A, 7 filings Feb 14, 2022 to Nov 14, 202538
  • NORTH RUN CAPITAL, LPSCHEDULE 13G/A, 5 filings Feb 14, 2024 to Nov 13, 202539
  • Sandra F. PessinSCHEDULE 13D/A, 2 filings Apr 23, 2025 to Aug 22, 202540
  • Thomas A. Satterfield Jr.SCHEDULE 13G/A, 4 filings Mar 23, 2022 to Feb 12, 202541
  • Veradace Capital Management LLCSC 13D, 3 filings Feb 15, 2022 to Dec 29, 202342
  • Roy T. EddlemanSC 13D/A, 1 filing Feb 15, 202343

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Apr 18, 2025Raised $1.6 million in a private offering of equity Form D: 11 investors so far Form D
  2. Dec 13, 2023Raised $7 million in a private offering of equity Form D: 58 investors so far Form D
  3. Mar 2, 2022Raised $3 million in a private offering of equity Form D: 38 investors so far Form D

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43